If you haven’t figured out already, BBK looooooooves metrics. It’s something we often talk about in our blog (Real-Time Enrollment Data, Right Now). Oh and let’s not forget, the development of our patient recruitment management system, TrialCentralNet(SM). That all being said, we are excited to continue our campaign for the importance of metrics. Next stop? Allan Lloyd’s Patient Recruitment and Retention Summit in Chicago, October 23rd-25th.
On Fridays at BBK, the entire company comes together to talk about the latest and greatest happening in our industry; something we call the Lunch and Learn. You can see some of the topics discussed by searching #BBKLnL on Twitter. Last Friday’s Social Media Lunch and Learn was of epic proportions…if I do say so myself. As the clock struck noon, the main conference room was buzzing with energy (the pizza and soda may have had something to do with that), and the social media team was sporting our beloved BBK softball jersey. BBK Worldwide anxiously awaited a presentation on how we have built our brand through social media. The theme of the hour took off when Aaron Fleishman, Director of Social Innovation, said, “Building our social media experience has really been a team effort. It’s our collective voice”. What happened next was any presenter’s dream: an insightful, engaging, educational conversation among the leaders in patient recruitment.
To begin, Matt Kibby, Global Operations Leader, began walking us through the inspiration behind, 2012 is so 2003: It’s natural to resist change, but it’s our job to educate our clients of the latest strategies in patient recruitment. As innovators in the industry, BBK is constantly trying to embrace change and challenge the status quo. The conversation then shifted to creating a program that fits: analyzing each protocol from a patient recruitment perspective and understanding all the vital facets of the study to develop a strategy that meets recruitment and budget requirements.
“We need more information; it’s what we’re craving for. We want trials to succeed; we want to be a part of the overall understanding of our disease, work with us.” – Jeri Burtchell
Social media provides a great opportunity to engage patients, helping them to understand the science behind clinical research. Putting the theory into practice requires a tactical approach.
It’s been quite a challenge for the healthcare industry to adapt to the social media world. Even with these challenges, we’ve seen some great strides in adapting to social media. One of the ways we’ve seen some growth is through Twitter chats. A number of individuals in the health industry have launched Twitter chats, conversations designed to encourage dialogues around issues related to marketing and healthcare, health communications, patient care, and other topics. Here are a few of BBK’s favorites, and I encourage everyone to get involved.
As my colleague Jaime Cohen discussed in a previous blog, BBK continues to establish key alliance partners around the world to support the growth of patient recruitment. Today marks the first blog in a new series on multinational studies in patient recruitment. So let’s dive into the media buying challenges and opportunities that we work through on a daily basis. How do we determine what works where and for who?
You may be wondering: how is BBK Worldwide using social media at the 48th Annual DIA Meeting this year? Wonder no more! We’re pulling out all the stops to be your #1 resource to stay up to date on all the happenings at the DIA. Here’s a brief rundown of our social media outlets and how you can get involved, share your experiences, and join the conversation even if you’re not attending.
One of the most interesting parts of my job is speaking with potential customers about their upcoming or ongoing studies. With each conversation, I get the opportunity to learn more about their exciting developments and medical advancements, many of which are happening in BBK’s backyard of Boston. My colleagues and I talk to clinical teams from companies of all sizes, and though each team has their own questions and concerns, the underlying objective of each conversation is the same: how can we work together to achieve predictable, on-time enrollment for a given study (or franchise).
Having played a significant role in recruiting patients to clinical trials for more years than I care to admit, I've learned a thing or two about how the medical community relates to the option of clinical trials for their patients. Here it goes: